ConductScience.org, home

Paper6147754

Comparative biochemical properties of normal and activated human ras p21 protein.

McGrath JP and 3 others. Nature, 1984. Cited by 648 papers, by iCite.

Cite this record

ConductScience Library. Comparative biochemical properties of normal and activated human ras p21 protein. Papers, record 6147754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6147754

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative biochemical properties of normal and activated human ras p21 protein.
PubMed
Journal
Nature
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
648
iCite
Relative citation ratio, by iCite
12.8
iCite
Revised in PubMed
2019-06-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McGrath JPJ P
2Capon DJD J
3Goeddel DVD V
4Levinson ADA D

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNAMajor topic
Neoplasm ProteinsMajor topic
OncogenesMajor topic
Cloning, Molecular
DNA Restriction Enzymes
Escherichia coli
GTP Phosphohydrolases
Guanosine Triphosphate
Humans
Mutation
Oncogene Protein p21(ras)
Phosphorylation
Protein Binding
Proto-Oncogene Proteins p21(ras)
RNA, Messenger
Substrate Specificity

Source PubMed

Download CSV of topics

Cited by207

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 648 citations.

PMIDTitleJournalYearIn PapersSource
42270775Targeting ATF3-mediated asparagine biosynthesis reverses acquired resistance to KRASG12C inhibitors.Oncogene2026https://conductscience.org/library/papers/42270775PubMed
39638567"Undruggable KRAS": druggable after all.Genes Dev2025https://conductscience.org/library/papers/39638567PubMed
38888731RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists.Endocr Pathol2024https://conductscience.org/library/papers/38888731PubMed
38882681Isomer-sourced structure iteration methods for in silico development of inhibitors: Inducing GTP-bound NRAS-Q61 oncogenic mutations to an "off-like" state.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/38882681PubMed
38570454Measurement of KRAS-GTPase Activity.Methods Mol Biol2024https://conductscience.org/library/papers/38570454PubMed
37833074Structural insights into the complex of oncogenic KRas4BG12V and Rgl2, a RalA/B activator.Life Sci Alliance2024https://conductscience.org/library/papers/37833074PubMed
37676964Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors.Science2023https://conductscience.org/library/papers/37676964PubMed
35966590Conquering oncogenic KRAS and its bypass mechanisms.Theranostics2022https://conductscience.org/library/papers/35966590PubMed
35582595Targeting the "undruggable" RAS - new strategies - new hope?Cancer Drug Resist2019https://conductscience.org/library/papers/35582595PubMed
35373279Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention.Cancer Discov2022https://conductscience.org/library/papers/35373279PubMed
35098800KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block.Ther Adv Respir Dis2022https://conductscience.org/library/papers/35098800PubMed
35070984Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer.Front Oncol2021https://conductscience.org/library/papers/35070984PubMed
34220225Analysis of RAS gene mutations in cytogenetically normal de novo acute myeloid leukemia patients reveals some novel alterations.Saudi J Biol Sci2021https://conductscience.org/library/papers/34220225PubMed
32797215RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics.Biochem J2020https://conductscience.org/library/papers/32797215PubMed
32689909Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations.Thyroid2021https://conductscience.org/library/papers/32689909PubMed
30224050Water Distribution within Wild-Type NRas Protein and Q61 Mutants during Unrestrained QM/MM Dynamics.Biophys J2018https://conductscience.org/library/papers/30224050PubMed
28448128Total Chemical Synthesis and Folding of All-l and All-d Variants of Oncogenic KRas(G12V).J Am Chem Soc2017https://conductscience.org/library/papers/28448128PubMed
27412009Pathogenetics of the RASopathies.Hum Mol Genet2016https://conductscience.org/library/papers/27412009PubMed
26765565Mapping the functional versatility and fragility of Ras GTPase signaling circuits through in vitro network reconstitution.Elife2016https://conductscience.org/library/papers/26765565PubMed
26344768Cross-Talk between Carbon Metabolism and the DNA Damage Response in S. cerevisiae.Cell Rep2015https://conductscience.org/library/papers/26344768PubMed

See all 207 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
H3P16644914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
HRAS3265PubTator's text mininghttps://conductscience.org/library/genes/3265NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6147754

GET https://conductscience.org/api/papers/v1/6147754/cited_by?page=2